Regeneron Pharmaceuticals Moves Up In Analyst Rankings, Passing Harman International Industries
October 17, 2014 at 11:51 AM EDT
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Regeneron Pharmaceuticals, Inc. (REGN) has taken over the #148 spot from Harman International Industries, Inc..